Related Experiment Video
Updated: Aug 16, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Triple coronary bypass in a child with homozygous familial hypercholesterolemia
Mehmet Salih Bilal1, Numan Ali Aydemir, Nihat Cine
1Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey. mehmetkaplan@superonline.com
Insights
A 12-year-old girl with familial homozygous hypercholesterolemia underwent triple coronary bypass surgery due to severe atherosclerosis. She is now in good condition, managed with lipid-lowering therapy and apheresis.
Area of Science:
- Cardiovascular Surgery
- Pediatric Cardiology
- Medical Genetics
Background:
- Familial homozygous hypercholesterolemia (HoFH) is a rare genetic disorder causing extremely high cholesterol levels.
- Severe coronary atherosclerosis in pediatric patients is uncommon but can lead to critical cardiac events.
- Early diagnosis and aggressive management are crucial for HoFH patients to prevent premature cardiovascular disease.
Observation:
- A 12-year-old female presented with extremely high total cholesterol (1300 mg/dL) and extensive coronary atherosclerosis.
- She had a history of successful out-of-hospital cardiopulmonary resuscitation due to a cardiac event.
- Angiography revealed significant three-vessel disease, including stenosis in the right coronary and left coronary ostia.
Findings:
- The patient underwent a successful triple coronary bypass procedure using arterial and venous grafts.
- Grafts included left internal thoracic artery (LITA) to the left anterior descending artery, radial artery to the obtuse marginal artery, and saphenous vein graft to the right posterior descending artery.
- Post-operative angiography confirmed successful revascularization.
Implications:
- This case highlights the feasibility and success of coronary artery bypass grafting in pediatric patients with severe HoFH and atherosclerosis.
- Intensive lipid-lowering therapy combined with weekly lipid apheresis is essential for long-term management.
- Aggressive surgical and medical interventions can improve outcomes for young patients with this severe genetic lipid disorder.
Abstract:
Here we report triple coronary bypass procedure in a 12-year-old girl with familial homozygous hypercholesterolemia and extensive coronary atherosclerosis. She had successful cardiopulmonary resuscitation at home by her father 4 months before the operation. Total cholesterol level was 1300 mg/dL initially without antilipidemic treatment. Extensive three vessel disease with right coronary proximal stenosis and left coronary ostial stenoses was determined by angiography. Left internal thoracic artery, left radial artery, and saphenous vein grafts were used for coronary revascularization. Saphenous vein graft to right posterior descending artery, radial artery graft to obtuse marginal artery, and LITA to left anterior descending artery anastomoses were performed consecutively. Ten months after the operation, she is in good condition under intensive antilipidemic therapy and weekly lipid apheresis.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Atherosclerosis III: Management
Mitral Stenosis III: Medical Management
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
